1 |
Burstein B, Anderson G, Yannopoulos A. Prevalence of serious bacterial infections among febrile infants 90 days or younger in a Canadian urban pediatric emergency department during the COVID-19 pandemic. JAMA Netw Open. 2021;4(7): e2116919.
|
2 |
Aronson PL, Thurm C, Alpern ER, Alessandrini EA, Williams DJ, Shah SS, et al. Variation in care of the febrile young infant <90 days in US pediatric emergency departments. Pediatrics. 2014; 134(4):667-77.
|
3 |
Dyer H. Evaluation and management of the febrile young infant (<90 days old) in the absence of universally accepted criteria for the risk of serious bacterial infection (SBI). Curr Probl Pediatr Adolesc Health Care. 2021; 51(4):100997.
|
4 |
Biondi EA, Byington CL. Evaluation and management of febrile, well-appearing young infants. Infect Dis Clin North Am. 2015; 29(3):575-85.
|
5 |
Gomez B, Mintegi S, Bressan S, Da Dalt L, Gervaix A, Lacroix L, et al. Validation of the “step-by-step” approach in the management of young febrile infants. Pediatrics. 2016; 138(2): e20154381.
|
6 |
Pantell RH, Roberts KB, Adams WG, Dreyer BP, Kuppermann N, O’Leary ST, et al. Evaluation and management of well-appearing febrile infants 8 to 60 days old. Pediatrics. 2021;148(2):e2021052228.
|
7 |
Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med.ed. 2005; 6(1):2-8.
|
8 |
Graaf S, Keuning MW, Pajkrt D, Plötz FB. Fever without a source in children: international comparison of guidelines. World J Pediatr. 2023; 19(2):120-8.
|
9 |
SAS Institute Inc. Sample 58775: estimating nonlinear combinations of model parameters. Available at: https://support.sas.com/kb/58/775.html
|
10 |
SAS Institute Inc. Sample 25018: plot ROC curve with cutpoint labeling and optimal cutpoint analysis. Available at: https://support.sas.com/kb/25/018.html
|
11 |
Yo CH, Hsieh PS, Lee SH, Wu JY, Chang SS, Tasi KC, et al. Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis. Ann Emerg Med. 2012; 60(5): 591-600.
|
12 |
Mahajan P, VanBuren JM, Tzimenatos L, Cruz AT, Vitale M, Powell EC, et al. Serious bacterial infections in young febrile infants with positive urinalysis results. Pediatrics. 2022; 150(4): e2021055633.
|
13 |
England JT, Del Vecchio MT, Aronoff SC. Use of serum procalcitonin in evaluation of febrile infants: a meta-analysis of 2317 patients. J Emerg Med. 2014; 47(6): 682-8.
|